Dr. John I. Bell, MD, is Chairman-Partnership Board at Oxford Centre for Diabetes Endocrinology & Metabolism, Chairman at GMEC Management Co. Ltd., Chairman at Office for Strategic Co-ordination of Health Research, Chairman at The Oxford Health Alliance and Non-Executive Director at The Jenner Institute.
He is on the Board of Directors at Oxford Sciences Innovation Plc, Immunocore Ltd., Roche Holding AG, Oxagen Ltd., F. Hoffmann-La Roche Ltd., Genentech, Inc., Genomics England Ltd., Oxford University Hospitals NHS Trust, The Gray Laboratory Cancer Research Trust, Rhodes Trust and The Ewelme Almshouse Charity. Dr. Bell was previously employed as President by The Academy of Medical Sciences, Founder by The Wellcome Trust Centre for Human Genetics, Chairman-Medicine Department & Professor by University of Oxford, and Independent Non-Executive Director by Avidex Ltd.
He also served on the board at Atopix Therapeutics Ltd.
He received his undergraduate degree from Magdalen College School Oxford Ltd, an undergraduate degree from the University of Alberta and a doctorate degree from Magdalen College School Oxford Ltd.